X @Bloomberg

Eli Lilly and Novo Nordisk plan to start selling their popular obesity shots to employers through a new approach that would bypass traditional drug sales channels in an effort to expand access to the costly weight-loss medicines. https://t.co/wywq3jyGQ9 ...